EAM
SNDX icon

Eventide Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Eventide Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,238,196
Closed -$26M – 303
2025
Q4 		$26M Buy
1,238,196
+249,710
+25% +$4.36M 0.41% 88
2025
Q3 		$15.2M Sell
988,486
-425,595
-30% -$5.57M 0.25% 113
2025
Q2 		$13.2M Buy
1,414,081
+236,019
+20% +$2.6M 0.23% 116
2025
Q1 		$14.5M Hold
1,178,062
– – 0.29% 102
2024
Q4 		$15.6M Buy
1,178,062
+391,072
+50% +$6.69M 0.28% 110
2024
Q3 		$15.1M Buy
+786,990
New +$16.3M 0.26% 102
2022
Q2 		– Sell
-1,165,000
Closed -$20.2M – 145
2022
Q1 		$20.2M Hold
1,165,000
– – 0.32% 87
2021
Q4 		$25.5M Hold
1,165,000
– – 0.33% 83
2021
Q3 		$22.3M Buy
1,165,000
+462,652
+66% +$7.71M 0.29% 89
2021
Q2 		$12.1M Sell
702,348
-1,314,645
-65% -$24.1M 0.16% 113
2021
Q1 		$45.1M Buy
2,016,993
+70,993
+4% +$1.6M 0.67% 56
2020
Q4 		$43.3M Buy
1,946,000
+1,246,800
+178% +$25.9M 0.66% 54
2020
Q3 		$10.3M Buy
699,200
+206,700
+42% +$3.15M 0.2% 102
2020
Q2 		$7.3M Buy
492,500
+265,820
+117% +$4.05M 0.16% 99
2020
Q1 		$2.49M Buy
+226,680
New +$2.13M 0.08% 105
2017
Q4 		– Sell
-225,000
Closed -$2.63M – 145
2017
Q3 		$2.63M Hold
225,000
– – 0.15% 96
2017
Q2 		$3.14M Buy
+225,000
New +$2.57M 0.2% 87

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Eventide Asset Management's SNDX Position: Q1 2026 in Review

Eventide Asset Management sold out of Syndax Pharmaceuticals (SNDX) in Q1 2026, closing a stake of 1,238,196 shares — an estimated $26M sold.

Eventide Asset Management first reported a position in SNDX in Q2 2017 and held it in 17 quarters. The position peaked at $45.1M in Q1 2021. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Eventide Asset Management reported no remaining Syndax Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Eventide Asset Management sold 1,238,196 Syndax Pharmaceuticals shares in Q1 2026, an estimated $26M.
  • Eventide Asset Management first reported a position in Syndax Pharmaceuticals in Q2 2017 and held it in 17 quarters.
  • Eventide Asset Management's Syndax Pharmaceuticals position peaked at $45.1M in Q1 2021.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.